December 7, 2010 – A new bioresorbable stent scaffold can be overinflated by more than 25 percent without cracking or crazing. New data from Arterial Remodeling Technologies (ART) show that its bioresorbable polylactic acid (PLA) stent platform is designed to avoid malapposition.
Transcatheter valve replacement, especially transcatheter aortic valve implantation (TAVI), took center stage at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium this fall in Washington, D.C. This highlights the fact the event has significantly evolved from an angioplasty meeting of 250 interventional cardiologists in the late 1980s.
Technology in the field of nuclear cardiac imaging — single photon emission computed tomography (SPECT) and positron emission tomography (PET) — has been somewhat stagnant over the past decade. However, there are some recent advancements in both radiotracers and hardware that could change this field of imaging.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
As production of molybdenum-99 returns to normal with the Canadian Chalk River Laboratories reactor back online and the supply of 99m-technetium stabilizes, the nuclear cardiology community is anxiously waiting to see if procedure volumes will rebound.
December 6, 2010 – A new, alcohol free disinfectant wipe is safe for use on ultrasound transducers and probes, mammography compressor plates and other non-surgical surfaces. The Protex Disinfectant Wipe, by Parker Laboratories, eliminates bacteria, viruses and fungi with just one wipe.
December 6, 2010 - A European court has struck a blow to Boston Scientific's alleged patent infringement case against OrbusNeich. The case is viewed by OrbusNeich as an unsuccessful retaliatory litigation effort to distract the marketplace from OrbusNeich's pending patent infringement and theft of trade secret case against Boston Scientific in the United States.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
December 6, 2010 – A new sleep study investigating the link between sleep disorders and cardiovascular disease will use the Somte PSG portable sleep-testing system, by Compumedics. The Multi-Ethnic Study of Atherosclerosis (MESA) Sleep Study will focus on various ethnic and racial populations.
December 6, 2010 – A Windows 7-compatible version of an ECG management software system will be available in the second quarter of 2011. The Global ECG Management Software (GEMS 4.0) software, by CardioComm Solutions, will encompass the full line of arrhythmia monitoring modules. It will also have multiple report-sending options, along with easy-to-use, customizable workflow features.
December 6, 2010 – Cordis Corp. has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the Ostial Pro Stent Positioning System.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 6, 2010 – The U.S. Food and Drug Administration (FDA) has given conditional approval for a trial that will investigate the role of a device in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI). The MINI-AMI trial will use the Impella 2.5, from Abiomed, for 24 hours following primary percutaneous intervention (PCI).
December 6, 2010 - A blood vessel dysfunction that is linked to cardiovascular illness also appears to play a role in the development of Alzheimer's disease. Supporting data from the study was published in Circulation Research: Journal of the American Heart Association.
December 6, 2010 – A new stent shows favorable outcomes compared to bare metal stents (BMS) for treating coronary artery bifurcation lesions. Data for the Genous Stent, from OrbusNeich, was published online in the journal, Atherosclerosis.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
December 6, 2010 – The American College of Cardiology (ACC) has partnered with Philips Healthcare on a new Hospital to Home (H2H) Learning Destination that will show how to improve the continuum of care. It will be featured at the ACC’s 60th Annual Expo in New Orleans.
December 6, 2010 – A panel of medical imaging experts discussed medical imaging appropriateness, ionizing radiation and efforts to curb overutilization, decrease radiation dose and educate patients.
December 3, 2010 – The initial patients have been enrolled in a trial for treating atrial fibrillation (AF). The DEEP AF trial will evaluate the safety and efficacy of a dual epicardial/endocardial procedure, or hybrid procedure, using AtriCure’s minimally invasive surgical ablation platform. In addition, it will use Thermocool catheter ablation products from Biosense Webster.